Scinovex
articleTop 10% cited

Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primate

Movement Disorders · 1991 · Vol. 6(4) · pp. 288–292
Tipu Z. AzizDavid PeggsM.A. SambrookAlan R. Crossman

Abstract

Central to the neural mechanism of MPTP-induced parkinsonism is overactivity of the subthalamic nucleus. Lesion of the subthalamic nucleus has therefore been performed in two primates with this condition and found to produce a remarkable amelioration of the disorder.

Neurological disorders and treatmentsParkinson's Disease Mechanisms and TreatmentsNeuroscience and Neuropharmacology ResearchMPTPSubthalamic nucleusParkinsonismLesionNucleusNeuroscienceParkinson's diseaseMedicinePsychologyPathology

MeSH terms

AnimalsBrain MappingDominance, CerebralMacaca fascicularisNeurologic ExaminationParkinson Disease, SecondaryThalamic Nuclei1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineRadiosurgery
Citations
536
FWCI
10.06
field-weighted impact
References
24
Percentile
99%
vs. same field & year
Citations per year
Cited by
Deep brain stimulation for Parkinson’s disease
Current Opinion in Neurobiology · 2003 · 1,022 citations
Pathophysiology of Parkinsonism
Clinical Neurophysiology · 2008 · 537 citations
Functional and pathophysiological models of the basal ganglia
Current Opinion in Neurobiology · 1996 · 736 citations
Deep Brain Stimulation for Parkinson Disease
Archives of Neurology · 2010 · 955 citations
References
Parkinsonism
Neurology · 1967 · 11,943 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primate · Scinovex